Reactive oxygen intermediates and eicosanoid production by Kupffer cells and infiltrated macrophages in acute and chronic liver injury induced in rats by CCl4
L. Alric et al., Reactive oxygen intermediates and eicosanoid production by Kupffer cells and infiltrated macrophages in acute and chronic liver injury induced in rats by CCl4, INFLAMM RES, 49(12), 2000, pp. 700-707
Objective and Design: The aim of the present study was to characterize duri
ng acute and chronic liver injury induced by CCl4, macrophage phenotypes an
d whether a change in reactive oxygen intermediates (ROI) and eicosanoids p
roduction by Kupffer cells (KC) was observed.
Material and Methods: Liver steato-necrosis and cirrhosis were induced in r
ats after 3 weeks and 9 weeks of CCl4 intoxication, respectively. Monocytes
and tissue macrophages were identified by immunohistochemical study using
monoclonal antibodies ED-1 and tissue macrophages using the antibody ED-2.
The release of ROI and eicosanoids in response to the phorbol ester TPA (pr
otein kinase activator) and to the calcium ionophore A23187 was assessed in
cultivated cells.
Results: As compared to healthy controls, livers of rats with steato-necros
is or cirrhosis exhibited a significant increase of ED-1 and ED-2 positive
cells. Only KC from rats with liver steato-necrosis were found to have high
er A23187, TPA + A23187 or opsonized zymosan induced ROI production than he
althy controls (p < 0.01). After TPA + A23187 or opsonized zymosan stimulat
ion, KC from both rats with steato-necrosis or cirrhosis produced more TxB2
and leukotrienes and less PGE2 as compared to healthy controls (p<0.05).
Conclusions: These results suggest an influx of monocytes into the liver du
ring acute and chronic injury induced by CCl4. Functional changes of this i
nflammatory infiltrate have been demonstrated with an increase of ROI produ
ction only in the early stage of liver injury whereas a rise in KC leukotri
ene production and an imbalance between cytoprotective and cytotoxic prosta
noids were observed at all stages of liver disease.